-
ABT-737 for Mitochondrial Apoptosis Assays
2026-09-23
Use ABT-737 to probe BCL-2-family dependence and apoptosis in cancer models, then pair cell-death measurements with mitochondrial mRNA imaging to ask what changes inside mitochondria. This workflow connects a practical BH3-mimetic perturbation to super-resolution methods while clearly separating established findings from experiments that still need validation.
-
GSTA1 Amplifies α-Amanitin Liver Injury
2026-09-23
This study identifies GSTA1 as an unexpected pathogenic driver in α-amanitin-induced hepatotoxicity rather than a uniformly protective antioxidant enzyme. By combining mouse toxicology, multi-omics, interaction assays, and genetic experiments, the authors link GSTA1 upregulation to glutathione depletion, reactive oxygen species accumulation, and hepatocyte injury.
-
STT3A–FCN3 Glycosylation in HCC Progression
2026-09-22
The reference study identifies an STT3A–FCN3–APC/Wnt/β-catenin pathway linking aberrant N-glycosylation to regulatory T-cell activation and hepatocellular carcinoma progression. Its combination of site-directed glycosylation analysis, genetic perturbation, cell assays, and xenograft experiments provides a framework for distinguishing global glycosylation effects from FCN3-specific mechanisms.
-
Sodium-Driven Mitochondrial Failure in NECSO
2026-09-22
Qiao and colleagues identify mitochondrial energy failure as the mechanistic link between TRPM4-mediated sodium influx and necrosis by sodium overload (NECSO). Their findings connect mitochondrial sodium accumulation, NCLX-dependent calcium loss, impaired oxidative metabolism, ATP depletion, and Na/K-ATPase failure into a coherent pathway that explains cell swelling and lysis.
-
(Z)-4-Hydroxytamoxifen in Relapse Models
2026-09-21
A mechanistic and translational framework for using (Z)-4-Hydroxytamoxifen to interrogate estrogen receptor biology while strategically integrating proliferation-tracing models of breast cancer relapse.
-
How Sodium Overload Executes NECSO
2026-09-21
Qiao and colleagues show that TRPM4-driven sodium entry causes necrosis through mitochondrial energy failure, not simply through osmotic swelling. Sodium accumulation in mitochondria alters NCLX-dependent calcium handling, suppresses oxidative phosphorylation and the TCA cycle, depletes ATP, and ultimately disables Na/K-ATPase-dependent ion homeostasis.
-
RSL3: Translating Ferroptosis Mechanisms
2026-09-20
A thought-leadership guide to using RSL3 as a mechanistic GPX4 probe, validating ferroptosis rigorously, interpreting oncogenic RAS vulnerability, and advancing preclinical findings toward translationally meaningful decisions.
-
D-N-Acetylgalactosamine Workflow Guide
2026-09-19
D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity reagent for aqueous or DMSO-based studies of glycoprotein composition, brain heteropolysaccharides, and related glycosylation workflows. It should not be used in ethanol-based preparations or for long-term storage of solutions; prepare working solutions close to use and store the solid at -20°C.
-
Irinotecan Beyond Cytotoxicity: Assay Design
2026-09-18
Irinotecan (CPT-11) is more than a topoisomerase I inhibitor: it can serve as a layered research perturbation linking tumor DNA damage with chemotherapy-associated gut–liver injury. This article translates recent mechanistic evidence into practical assay and workflow decisions for colorectal cancer research.
-
Cy3 NHS ester (non-sulfonated) Workflow Guide
2026-09-18
Cy3 NHS ester (non-sulfonated), SKU A8100, provides an orange fluorescent NHS ester for labeling accessible amino groups in proteins, peptides, and oligonucleotides. It is appropriate when an organic co-solvent is compatible with the biomolecule, but it should not be selected for water-only labeling or long-term storage of prepared dye solutions.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-09-17
Zhang and colleagues show that CDC42-dependent epithelial polarity regulates the intestinal stem cell to transit-amplifying cell transition through a YAP/TAZ–Ereg–EGFR–mTOR cascade, rather than solely through canonical Wnt signaling. Genetic and pharmacological rescue experiments distinguish restoration of crypt proliferation and cell-fate balance from restoration of epithelial polarity, providing a useful framework for studying intestinal homeostasis.
-
G007-LK Tankyrase 1/2 Inhibitor: Research Workflows
2026-09-17
G007-LK provides a practical route to connect tankyrase enzymatic inhibition with AXIN stabilization, β-catenin degradation, and downstream growth phenotypes. This guide translates those mechanisms into reproducible Wnt reporter, protein, colony-formation, and Hippo pathway workflows for cancer biology research.
-
Topotecan in First-Line Small Cell Lung Cancer
2026-09-16
This reference article examines whether topotecan-based combinations could improve first-line treatment for small cell lung cancer, where initial chemotherapy responses are often followed by relapse and resistance. Its central contribution is a clinically focused synthesis of response and toxicity signals from phase II studies, emphasizing regimen design, reversible neutropenia, and the need for confirmatory trials rather than presenting a definitive practice-changing conclusion.
-
PBS Liposomes: Reliable Macrophage Controls
2026-09-16
Learn how PBS Liposomes (SKU K2722) improve interpretation of in vivo macrophage depletion studies by separating liposome exposure from clodronate-specific apoptosis. This scenario-driven guide covers experimental design, assay compatibility, storage, data interpretation, and practical vendor selection.
-
HDAC Inhibitors Repress NUT Function in NUT Carcinoma
2026-09-15
The reference study developed a dCas9-based reporter screen that identified chemically diverse HDAC inhibitors as suppressors of BRD4-NUT transcriptional activity. Panobinostat and IRBM6 reduced megadomain-associated oncogene expression, promoted differentiation, and suppressed tumor growth, supporting chromatin acetylation as a therapeutic vulnerability in NUT carcinoma.